Press release
Cancer Biomarkers Market worth $28.2 billion by 2026 - Leading Key Players are Illumina, Inc. (US), Bio-Rad Laboratories, Inc. (US), Abbott Laboratories (US), bioMérieux SA (US)
Cancer Biomarkers Market
Browse in-depth TOC on "Cancer Biomarkers Market"
229 - Tables
50 - Figures
287 - Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=202
The Growing preference for wireless connectivity among healthcare providers, Increasing incidence of cancer worldwide, increasing use of cancer biomarkers in drug discovery & development and increasing R&D on cancer biomarkers are among the other factors. Emerging economies such as India and Japan are providing lucrative opportunities for the players operating in the market.
The protein biomarkers segment accounted for the largest share of the cancer biomarkers market, by biomarker type segment, in 2020
Based on biomarkers type, the market is segmented into protein biomarkers, genetic biomarkers and other cancer biomarkers. The protein biomarkers segment accounted for the largest share of the cancer biomarker market, mainly due to rising technological advancements In the development of cancer biomarkers and increasing R&D on cancer biomarkers.
Lung cancer segment to register the highest growth rate during the forecast period
The cancer biomarker market is segmented into breast cancer, lung cancer, colorectal cancer, prostate cancer, melanoma, leukemia, thyroid cancer, bladder cancer, non-hodgkins lymphoma, kidney cancer and other cancer types based on cancer type. In 2020, the breast cancer segment accounted for the largest share of the cancer biomarkers market. The large share of this segment can mainly be attributed to the increasing incidence of cancer worldwide and increasing use of cancer biomarkers in drug discovery & development.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=202
The omics technology accounted for the largest share of the cancer biomarkers market, by profiling technology segment, in 2020
Based on profiling technology, the market has been segmented into omics technologies, imaging technologies, immunoassay, bioinformatics, and cytogenetics. In 2020, the omics technology segment accounted for the largest share of the cancer biomarker market, mainly due to the increasing use of cancer biomarkers in drug discovery & development and increasing R&D on cancer biomarkers.
The diagnostics segment accounted for the largest share of the cancer biomarkers market, by application segment, in 2020
Based on application, the cancer biomarker market has been segmented into diagnostics, research & development, prognostics, risk assessment, and other applications. In 2020, the diagnostics segment accounted for the largest share of the cancer biomarker market, mainly due to the increasing incidence of cancer worldwide and increasing use of cancer biomarkers in drug discovery & development.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=202
North America is the largest regional market for cancer biomarkers market
The global cancer biomarker market is segmented into five major regions - North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest regional market for market in 2020. The large share of North America in this market can be attributed to the rising technological advancements In the development of cancer biomarkers, increasing incidence of cancer worldwide, and increasing use of cancer biomarkers in drug discovery & development.
The major players operating in this Cancer Biomarkers Market are F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific, Inc. (US), QIAGEN N.V. (Netherlands), ; Illumina, Inc. (US), Bio-Rad Laboratories, Inc. (US), Abbott Laboratories (US), bioMérieux SA (US), Becton, Dickinson and Company (US), Merck Millipore (US), Agilent Technologies (US), Myriad Genetics, Inc. (US), Sysmex Corporation (Japan), Hologic, Inc. (US), Quest Diagnostics (US), Centogene N.V. (Germany), PerkinElmer, Inc.; (US), Siemens Healthineers (Germany), Exact Sciences (US), R&D Systems, Inc. (US), BioVision, Inc. (US), Olink (Sweden), Asuragen, Inc. (US), Meso Scale Diagnostics, LLC (US), Invivoscribe, Inc. (US), Seegene Technologies, Inc. (South Korea).
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Biomarkers Market worth $28.2 billion by 2026 - Leading Key Players are Illumina, Inc. (US), Bio-Rad Laboratories, Inc. (US), Abbott Laboratories (US), bioMérieux SA (US) here
News-ID: 2584521 • Views: …
More Releases from MarketsandMarkets™ INC
Microscopy Market worth $9.5 billion by 2027 - Exclusive Report by MarketsandMar …
Microscopy Market is projected to grow from USD 7.2 billion in 2022 to USD 9.5 billion by 2027, at a CAGR of 5.8% from 2022 to 2027, according to a new report by MarketsandMarkets™. Factors such as advancement in technology of microscopes, growing interest of nanotechnology and regenerative medicines, better regulatory procedures along with growing application scope and high demand from key end users are driving the market growth. Moreover,…
Bariatric Surgery Devices Market worth $2.4 billion by 2027 - Exclusive Report b …
Bariatric Surgery Devices Market is projected to grow from USD 1.9 billion in 2022 to USD 2.4 billion by 2027, at a CAGR of 5.4% from 2022 to 2027, according to a new report by MarketsandMarkets™. Emerging countries have offered significant growth opportunities to major market players, which is further expected to support market growth.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173150134
Browse in-depth TOC on "Bariatric Surgery Devices Market"
130 - Tables
35 -…
Veterinary Diagnostics Market worth $4.4 billion by 2027 - Exclusive Report by M …
Veterinary Diagnostics Market is projected to grow from USD 2.8 billion in 2022 to USD 4.4 billion by 2027, at a CAGR of 9.2% from 2022 to 2027, according to a new report by MarketsandMarkets™. The growth can largely be attributed to the growth in the companion animal population, the increasing incidence of transboundary and zoonotic diseases and the rising demand for animal-derived food products. A surge in the overall…
Nuclear Medicine Market by 2026 - Global Trends, Share Analysis, Leading Players …
The nuclear medicine market is projected to reach USD 7.5 billion by 2026, growing at a CAGR of 9.0% during the forecast period.
Increasing incidence and prevalence of target conditions;
The rising incidence and prevalence of cancer and cardiovascular disease (CVD) is a key factor supporting market growth. Most cases can be prevented through early detection and treatment; nuclear medicine plays a significant role in these areas. According to the WHO, cancer…
More Releases for MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices
Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact!
Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices.
Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register
MarketsandMarkets presents…
Automotive Engineering Services Market | MarketsandMarkets
Automotive engineering services deal with the design and development of automotive components and related technologies to address complex technical challenges in the vehicle development value chain. The engineering service process starts with conceptualization, designing, prototyping, system integration, and testing. Automotive engineering services include vehicle connectivity services, ADAS (advanced driver-assistance systems) and safety systems, interior & exterior design and body engineering services, passenger comfort, and others. These services assess different areas…
Global Automotive Glass Market | MarketsandMarkets
The Automotive Glass Market is projected to grow at a CAGR of 4.80%, to reach a market size of $23.59 billion by 2025.
The global market is driven by increasing vehicle production (especially in the SUV segment), upcoming smart glass & device embedded glass technologies, and increasing glass applications to improve the aesthetics of the car.
The key players in the automotive glass market are Saint-Gobain (France), Asahi Glass (Japan), Fuyao…
Rolling Stock Market (2021-2025) | MarketsandMarkets
The global Rolling Stock Market is estimated to be $51.6 billion in 2020 and is projected to reach $64.3 billion by 2025, growing at a CAGR of 4.5% from 2020 to 2025.
Asia Oceania is estimated to lead the market in 2020; China, Japan, and India are the key contributors to the rolling stock market in the region. Increasing urbanization, adoption of public transport as a means of reducing traffic…
Automotive Logistics Market | MarketsandMarkets
The Automotive Logistics Market is estimated to be $284.1 billion in 2018 and is projected to reach $472.9 billion by 2025, at a CAGR of 7.55%.
Increasing vehicle production, upcoming infrastructure projects, and the advent of electric vehicles are the major reasons for market growth.
The automotive logistics market is consolidated and dominated by a few global players. The key players in the market are DHL (Germany), XPO (US), SNCF (France),…
Electric Bike Market 2020-2027 | MarketsandMarkets
The global E-Bike Market size is projected to grow to $70.0 billion by 2027 from $41.1 billion in 2020, at a CAGR of 7.9%.
Government initiatives towards clean environment and technology advancements such as connected electric bikes are driving the market growth.
The key players in the electric Bike industry are Accell Group N.V. (Netherlands), Pon. Bike (US), Merida Industry Co., Ltd. (Taiwan), Giant Manufacturing Co., Ltd. (Taiwan), and Yamaha…
